Safety and Feasibility of Transcatheter Aortic Valve Replacement in COVID-19 Patients: A Case Series

In 2020, the coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in interventional treatment for structural heart disease worldwide. In this context, the management of patients with symptomatic severe aortic stenosis (AS) or bioprosthetic valve dysfunction (BVD) represents a clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacomin, Enrico, Barioli, Alberto, Favero, Luca, Lanzellotti, Davide, Calzolari, Diego, Daniotti, Alessandro, Cernetti, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023787/
https://www.ncbi.nlm.nih.gov/pubmed/33840619
http://dx.doi.org/10.1016/j.carrev.2021.03.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023787/
https://www.ncbi.nlm.nih.gov/pubmed/33840619
http://dx.doi.org/10.1016/j.carrev.2021.03.022

Ejemplares similares